Search Results - "Nagendra, S. Ningaraj"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Role of KCNMA1 gene in breast cancer invasion and metastasis to brain by Khaitan, Divya, Sankpal, Umesh T, Weksler, Babette, Meister, Edward A, Romero, Ignacio A, Couraud, Pierre-Olivier, Ningaraj, Nagendra S

    Published in BMC cancer (29-07-2009)
    “…The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the metastatic process is…”
    Get full text
    Journal Article
  2. 2

    Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels by Ningaraj, Nagendra S, Rao, Mamatha, Hashizume, Kazuhiro, Asotra, Kamlesh, Black, Keith L

    “…The blood-brain tumor barrier (BTB) limits the delivery of therapeutic drugs to brain tumors. We demonstrate in a rat brain tumor (RG2) model an enhanced drug…”
    Get more information
    Journal Article
  3. 3

    Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model by Ningaraj, Nagendra S., Sankpal, Umesh T., Khaitan, Divya, Meister, Edward A., Vats, Tribhawan S.

    Published in Cancer biology & therapy (15-10-2009)
    “…Most anticancer drugs fail to impact patient survival since they fail to cross the blood-brain tumor barrier (BTB) at therapeutic levels. For example,…”
    Get full text
    Journal Article
  4. 4

    Modulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumor by Black, Keith L, Ningaraj, Nagendra S

    Published in Cancer control (01-05-2004)
    “…The blood-brain tumor barrier (BTB) significantly impedes delivery of most hydrophilic molecules to brain tumors. Several promising strategies, however, have…”
    Get more information
    Journal Article
  5. 5

    Drug delivery to brain tumours: challenges and progress by Ningaraj, Nagendra S

    Published in Expert opinion on drug delivery (01-07-2006)
    “…Nearly 12.5 million new cancer cases are diagnosed worldwide each year. Although new treatments have been developed, most new anticancer drugs that are…”
    Get more information
    Journal Article
  6. 6

    Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors by Khaitan, Divya, Ningaraj, Nagendra S

    Published in Frontiers in pharmacology (01-01-2013)
    “…Every year in the US, 20,000 new primary and nearly 200,000 metastatic brain tumor cases are reported. The cerebral microvessels/capillaries that form the…”
    Get full text
    Journal Article
  7. 7

    Activation of KATP channels increases anticancer drug delivery to brain tumors and survival by NINGARAJ, Nagendra S, SANKPAL, Umesh T, KHAITAN, Divya, MEISTER, Edward A, VATS, Trib

    Published in European journal of pharmacology (14-01-2009)
    “…Several anticancer drugs are ineffective against brain tumor and do not impact patient survival because they fail to cross the blood-brain tumor barrier (BTB)…”
    Get full text
    Journal Article
  8. 8

    Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model by NINGARAJ, Nagendra S, RAO, Mamatha K, BLACK, Keith L

    Published in Cancer research (Chicago, Ill.) (15-12-2003)
    “…Brain tumor microvessels/capillaries limit drug delivery to tumors by forming a blood-brain tumor barrier (BTB). The BTB overexpresses ATP-sensitive potassium…”
    Get full text
    Journal Article
  9. 9

    Role of KCNMA1gene in breast cancer invasion and metastasis to brain by Khaitan, Divya, Sankpal, Umesh T, Weksler, Babette, Meister, Edward A, Romero, Ignacio A, Couraud, Pierre-Olivier, Ningaraj, Nagendra S

    Published in BMC cancer (29-07-2009)
    “…Abstract Background The prognosis for patients with breast tumor metastases to brain is extremely poor. Identification of prognostic molecular markers of the…”
    Get full text
    Journal Article
  10. 10

    Effect of disulfiram administration on glutamate uptake by synaptosomes in the rat brain by Mamatha, R K, Nagendra, S N

    Published in European journal of pharmacology (01-11-1994)
    “…Although disulfiram used as a pharmacological agent in the treatment of alcoholism is reported to act on both peripheral and central nervous systems with…”
    Get more information
    Journal Article
  11. 11

    Carbamoylation of Brain Glutamate Receptors by a Disulfiram Metabolite by Nagendra, S. Ningaraj, Faiman, Morris D., Davis, Kathleen, Wu, Jang-Yen, Newby, Xiangyue, Schloss, John V.

    Published in The Journal of biological chemistry (26-09-1997)
    “…S-Methyl-N,N-diethylthiolcarbamate sulfoxide (DETC-MeSO), a metabolite of the drug disulfiram, is a selective carbamoylating agent for sulfhydryl groups…”
    Get full text
    Journal Article
  12. 12

    Activation of K ATP channels increases anticancer drug delivery to brain tumors and survival by Ningaraj, Nagendra S., Sankpal, Umesh T., Khaitan, Divya, Meister, Edward A., Vats, Trib

    Published in European journal of pharmacology (14-01-2009)
    “…Several anticancer drugs are ineffective against brain tumor and do not impact patient survival because they fail to cross the blood-brain tumor barrier (BTB)…”
    Get full text
    Journal Article
  13. 13

    Molecular and Cellular Pharmacology: Activation of KATP channels increases anticancer drug delivery to brain tumors and survival by Ningaraj, Nagendra S, Sankpal, Umesh T, Khaitan, Divya, Meister, Edward A, Vats, Trib

    Published in European journal of pharmacology (01-01-2009)
    “…Several anticancer drugs are ineffective against brain tumor and do not impact patient survival because they fail to cross the blood-brain tumor barrier (BTB)…”
    Get full text
    Journal Article
  14. 14

    Calcium-dependent potassium channels as a target protein for modulation of the blood-brain tumor barrier by Ningaraj, Nagendra S, Rao, Mamatha, Black, Keith L

    Published in Drug news & perspectives (01-06-2003)
    “…Even though the blood-brain tumor barrier (BTB) is more permeable than the blood-brain barrier (BBB), the BTB still significantly restricts the delivery of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Neurotoxic effect of acamprosate, n-acetyl-homotaurine, in cultured neurons by Wu, J Y, Jin, H, Schloss, J V, Faiman, M D, Ningaraj, N S, Foos, T, Chen, W

    Published in Journal of biomedical science (01-01-2001)
    “…Acamprosate (AC), N-acetyl-homotaurine, has recently been introduced for treating alcohol craving and reducing relapses in weaned alcoholics. AC may exert its…”
    Get more information
    Journal Article
  17. 17

    S-methyl-N,N-diethylthiocarbamate sulfoxide elicits neuroprotective effect against N-methyl-D-aspartate receptor-mediated neurotoxicity by Ningaraj, N S, Chen, W, Schloss, J V, Faiman, M D, Wu, J Y

    Published in Journal of biomedical science (01-01-2001)
    “…Glutamatergic neurotransmission, particularly of the NMDA receptor type, has been implicated in the excitotoxic response to several external and internal…”
    Get more information
    Journal Article
  18. 18

    Disulfiram augments oxidative stress in rat brain following bilateral carotid artery occlusion by Ningaraj, N S, Rao, M K

    Published in Journal of biomedical science (1998)
    “…We examined the brain oxidative stress which accompanies 30 min of bilateral carotid artery ligation (BCAL) in terms of changes in brain levels of glutathione;…”
    Get more information
    Journal Article
  19. 19

    Glutathione Carbamoylation with S-Methyl N, N-diethylthiolcarbamate Sulfoxide and Sulfone : Mitochondrial Low Km Aldehyde Dehydrogenase Inhibition and Implications for Its Alcohol-Deterrent Action by Ningaraj, Nagendra S, Schloss, John V, Williams, Todd D, Faiman, Morris D

    Published in Biochemical pharmacology (15-03-1998)
    “…S-Methyl N, N-diethylthiolcarbamate sulfoxide (DETC-MeSO) and sulfone (DETC-MeSO 2) both inhibit rat liver low K m aldehyde dehydrogenase (ALDH 2) in vitro and…”
    Get full text
    Journal Article